Oncology Based In-vivo CRO market size, share and data analysis | forecast 2029

Oncology Based In-vivo CRO Market Report 2022 Forecasts 2029 By Type (Blood Cancer, Solid Tumor), By Region and History 2017-2021

Published On: Dec 2021

Format: PDF

Publisher: Calibre Research

Pages: 121

Report ID: 179473

CalibreResearch.com announces Latest research on the Oncology Based In-vivo CRO market is titled as Global Oncology Based In-vivo CRO Market Report 2022 by type, by application, by region and by major vendors. In this study, we have delivered detailed analysis about the global Oncology Based In-vivo CRO marketplace. It further delivers a brief overview of the world Oncology Based In-vivo CRO market with the help of all-inclusive segmentation that illustrates essential insightful details related to the certain industry.  

According to the recent survey, The global oncology based in-vivo CRO market size was valued at USD 1002.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2021 to 2029.

A few of the key market players operating in the Oncology Based In-vivo CRO market are: Charles River Laboratory, ICON Plc, Covance, Eurofins Scientific, Taconic Biosciences, Crown Bioscience, Toxikon, Inc., WuXi AppTec, EVOTEC, The Jackson Laboratory.

The solid excrescences dominated the request for oncology grounded in-vivo CRO and reckoned for the largest profit share of 49.2% in 2021. The factors responsible for advanced exploration in the field of solid excrescences are the presence of over 800 new motes that are under channel by large pharmaceutical companies, vacuity of subventions from institutes similar as NIH and NCI, and the being gap between demand and force of remedial treatments for solid cancer.  

Solid excrescences are cancer being within organs, muscles, or bones. These are generally addressed as lymphomas and sarcomas. The adding prevalence of cancer across the globe and growing interest of world agencies similar as the WHO in assaying their frequence, causative agents, and treatment options are boosting the R&D. For case, BioInvent, a Swedish CRO is presently performing multiple preclinical oncology exploration in collaboration with players similar as Bayer Healthcare, Daiichi Sankyo, and Servier.  

  • Report Coverage and Market Dynamics
  • PDF report and online dashboard will help you understand:
  • Oncology Based In-vivo CRO Competitive benchmarking
  • Oncology Based In-vivo CRO Market opportunities
  • Oncology Based In-vivo CRO Latest trends & dynamics
  • Oncology Based In-vivo CRO Key Market Strategies
  • Oncology Based In-vivo CRO Market forecasts
  • Oncology Based In-vivo CRO Company market shares
  • Oncology Based In-vivo CRO Top Investment Pockets
  •  

The competitive landscape of the global Oncology Based In-vivo CRO market has been evaluated widely for deeply recognizing the topmost ranking of the Oncology Based In-vivo CRO industry manufacturers along with highest revenue contributions, powerful infrastructure and robust foothold in the competitive environment as well as the elaboration of geographical footprint. The study analyzes manufacturers of the Oncology Based In-vivo CRO industry along with the demonstration of their company profile and current strategic initiatives enlarging the growth prospect for entire development of the global Oncology Based In-vivo CRO industry.

The global Oncology Based In-vivo CRO market report contains a comprehensive overview of the latest industry events and industrial happenings including mergers of large-scale vendors, acquisition programs, vital collaborations performed by several industry-level entities for scaling up the overall performance as well as potential strength of the global Oncology Based In-vivo CRO market.

Oncology Based In-vivo CRO Indication Outlook 2017 - 2029

Blood cancer

-Syngeneic model

-Patient Derived Xenograft (PDX)

-Xenograft

 

Solid tumors

-Syngeneic model

-Patient Derived Xenograft (PDX)

-Xenograft

 

Others

-Syngeneic model

-Patient Derived Xenograft (PDX)

-Xenograft

 

Above information is further split with respect to following geographies:  

North America segmented by countries:

• US

• Canada

• Mexico

 

Europe segmented by countries:

• UK

• Germany

• France

• Italy

• Russia

• Spain

• Switzerland

• Austria

• Belgium

• Rest of Europe

 

Asia Pacific segmented by countries:

• China

• Japan

• South Korea

• Indonesia

• Vietnam

• Philippines

• Australia

• Thailand

• Singapore

• Rest of APAC

 

Middle East segmented by countries:

• UAE

• Saudi Arabia

• Egypt

• South Africa

• Israel

• Rest of MEA

 

Latin America segmented by countries:

• Brazil

• Argentina

• Rest of Latin America

1 Market Overview

1.1 Product Overview and Scope of Oncology Based In-vivo CRO

1.2 Classification of Oncology Based In-vivo CRO by Type

1.2.1 Overview: Global Oncology Based In-vivo CRO Market Size by Type: 2020 Versus 2021 Versus 2029

1.2.2 Global Oncology Based In-vivo CRO Revenue Market Share by Type in 2020

1.3 Global Oncology Based In-vivo CRO Market by Application

1.3.1 Overview: Global Oncology Based In-vivo CRO Market Size by Application: 2020 Versus 2021 Versus 2029

1.4 Global Oncology Based In-vivo CRO Market Size & Forecast

1.5 Global Oncology Based In-vivo CRO Market Size and Forecast by Region

1.5.1 Global Oncology Based In-vivo CRO Market Size by Region: 2016 VS 2021 VS 2029

1.5.2 Global Oncology Based In-vivo CRO Market Size by Region, (2016-2021)

1.5.3 North America Oncology Based In-vivo CRO Market Size and Prospect (2016-2029)

1.5.4 Europe Oncology Based In-vivo CRO Market Size and Prospect (2016-2029)

1.5.5 Asia-Pacific Oncology Based In-vivo CRO Market Size and Prospect (2016-2029)

1.5.6 South America Oncology Based In-vivo CRO Market Size and Prospect (2016-2029)

1.5.7 Middle East and Africa Oncology Based In-vivo CRO Market Size and Prospect (2016-2029)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oncology Based In-vivo CRO Market Drivers

1.6.2 Oncology Based In-vivo CRO Market Restraints

1.6.3 Oncology Based In-vivo CRO Trends Analysis

1.6.4 COVID Impact Analysis

 

2 Company Profiles

Essity

3M

Otto Bock Healthcare

DeRoyal Industries, Inc.

Medi GmbH & Co. KG

Zimmer Biomet

Stryker

Orthosys

United Medicare

Sam Medical

 

2.1.1 Company Details

2.1.2 Company Major Business

2.1.3 Company Oncology Based In-vivo CRO Product and Solutions

2.1.4 Company Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Company Recent Developments and Future Plans

 

3 Market Competition, by Players

3.1 Global Oncology Based In-vivo CRO Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Oncology Based In-vivo CRO Players Market Share

3.2.2 Top 10 Oncology Based In-vivo CRO Players Market Share

3.2.3 Market Competition Trend

3.3 Oncology Based In-vivo CRO Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

 

4 Market Size Segment by Type

4.1 Global Oncology Based In-vivo CRO Revenue and Market Share by Type (2017-2021)

4.2 Global Oncology Based In-vivo CRO Market Forecast by Type (2021-2029)

 

5 Market Size Segment by Application

5.1 Global Oncology Based In-vivo CRO Revenue Market Share by Application (2017-2021)

5.2 Oncology Based In-vivo CRO Market Forecast by Application (2021-2029)

 

6 North America by Country, by Type, and by Application

6.1 North America Oncology Based In-vivo CRO Revenue by Type (2017-2029)

6.2 North America Oncology Based In-vivo CRO Revenue by Application (2017-2029)

6.3 North America Oncology Based In-vivo CRO Market Size by Country

6.3.1 North America Oncology Based In-vivo CRO Revenue by Country (2017-2029)

6.3.2 United States Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

6.3.3 Canada Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

6.3.4 Mexico Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

 

7 Europe by Country, by Type, and by Application

7.1 Europe Oncology Based In-vivo CRO Revenue by Type (2017-2029)

7.2 Europe Oncology Based In-vivo CRO Revenue by Application (2017-2029)

7.3 Europe Oncology Based In-vivo CRO Market Size by Country

7.3.1 Europe Oncology Based In-vivo CRO Revenue by Country (2017-2029)

7.3.2 Germany Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

7.3.3 France Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

7.3.4 United Kingdom Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

7.3.5 Russia Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

7.3.6 Italy Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

 

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oncology Based In-vivo CRO Revenue by Type (2017-2029)

8.2 Asia-Pacific Oncology Based In-vivo CRO Revenue by Application (2017-2029)

8.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region

8.3.1 Asia-Pacific Oncology Based In-vivo CRO Revenue by Region (2017-2029)

8.3.2 China Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

8.3.3 Japan Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

8.3.4 South Korea Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

8.3.5 India Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

8.3.6 Southeast Asia Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

8.3.7 Australia Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

 

9 South America by Country, by Type, and by Application

9.1 South America Oncology Based In-vivo CRO Revenue by Type (2017-2029)

9.2 South America Oncology Based In-vivo CRO Revenue by Application (2017-2029)

9.3 South America Oncology Based In-vivo CRO Market Size by Country

9.3.1 South America Oncology Based In-vivo CRO Revenue by Country (2017-2029)

9.3.2 Brazil Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

9.3.3 Argentina Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

 

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oncology Based In-vivo CRO Revenue by Type (2017-2029)

10.2 Middle East & Africa Oncology Based In-vivo CRO Revenue by Application (2017-2029)

10.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country

10.3.1 Middle East & Africa Oncology Based In-vivo CRO Revenue by Country (2017-2029)

10.3.2 Turkey Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

10.3.3 Saudi Arabia Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

10.3.4 UAE Oncology Based In-vivo CRO Market Size and Forecast (2017-2029)

 

11 Research Findings and Conclusion

 

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer